Table 2.

Physical function and triggering factors for SRE occurrence

No.	Age/Sex	Amyloidosis	Details of SRE	Treatment response	Triggers	Complications/comorbidities	PS ECOG
1	76/M	None	Femoral fracture	SD	Loss of balance Falling down	Peripheral neuropathy	2
2	47/M	None	Rib fracture Spinal cord compression	PD	None	None	2
3	56/M	None	Pelvic fracture	PD	Loss of balance Falling down	DM type 2 Orthostatic hypotension	4
4	55/M	None	Vertebral fracture Spinal cord compression	PD	None	Peripheral neuropathy	4
5	78/M	None	Sacral fracture Spinal cord compression	PD	None	None	3
6	77/M	None	Vertebral fracture Rib fracture	PD	None	DM type 2 Orthostatic hypotension	1
7	74/F	None	Vertebral fracture	PD	Loss of balance	Peripheral neuropathy	3
8	80/F	None	Vertebral fracture	PD	None	DM type 2 Muscle weakness	3
9	73/F	None	Femoral fracture	SD	Loss of balance Falling down	None	1
10	85/F	None	Vertebral fracture Spinal cord compression	PD	Falling down	None	1
11	59/F	None	Vertebral fracture	PD	None	None	1
12	73/F	Heart, tongue, skin	Femoral fracture	VGPR	Falling down	Muscle weakness Orthostatic hypotension	2
13	78/F	GI tract, skin, muscle	Vertebral fracture	VGPR	Loss of balance Falling down	Muscle weakness	1
14	70/M	Heart, kidney, GI tract	Rib fracture	VGPR	Falling down	DM type 2 Peripheral neuropathy Orthostatic hypotension	0

M male, F female, PS performance status, ECOG Eastern Cooperative Oncology Group, VGPR very good partial response, SD stable disease, PD progressive disease, GI gastrointestinal, DM diabetes mellitus